PCR148 Patient Involvement in the Development of Outcomes Measures Specific to Neuronopathic Gaucher Disease Type 2 and Type 3 to Assess HRQoL Over the Disease Journey
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.2083
https://www.valueinhealthjournal.com/article/S1098-3015(22)04288-7/fulltext
Section Title :
Section Order :
11639
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04288-7&doi=10.1016/j.jval.2022.09.2083